The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
January 30th 2025
The drug is a selective NaV1.8 pain signal inhibitor and is the first new class of medication to treat acute pain in over 20 years.
Drugs and Nutrients: Known Issues, Breaking News
August 6th 2014Just 20 or 30 years ago, mention of vitamin supplementation caused many health care professionals to talk about creating "expensive urine." Today, however, vitamin and nutrient supplementation has become an important health care intervention.
Read More
Vitamins and Supplements: What Do Patients Need?
August 6th 2014If pharmacists practice at the top of their licenses, they will integrate rewarding work conducted in OTC aisles by looking at each patient's total pharmacotherapy regimen-prescription medications, OTC products, and dietary supplements.
Read More
FDA Expands Access to Lumizyme, Drops Risk Mitigation Requirements
August 5th 2014With its expanded approval of Lumizyme (alglucosidase alfa) to treat all Pompe disease patients, regardless of age or time of disease onset, the FDA has eliminated the Risk Evaluation and Mitigation Strategy program that restricted the drug's use to those aged 8 years or older with late-onset disease.
Read More